Smoking, alcohol, drug use, abuse and dependence in narcolepsy and idiopathic hypersomnia: A case-control Study

Sleep

Volumn 39, Issue 3, 2016, Pages 573-580

  Barateau, Lucie ^a   Jaussent, Isabelle ^b   Lopez, Régis ^a,b,c   Boutrel, Benjamin ^d   Leu Semenescu, Smaranda ^c,e   Arnulf, Isabelle ^c,e   Dauvilliers, Yves ^a,b,c  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b INSERM   (France)

^c National Reference Centre for Orphan Diseases   (France)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Addiction; Hypersomnia; Hypocretin orexin; Narcolepsy; Substance abuse

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; MODAFINIL; OREXIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRINKING BEHAVIOR; DRUG ABUSE; DRUG DEPENDENCE; DRUG USE; FEMALE; HUMAN; HYPERSOMNIA; IDIOPATHIC DISEASE; IDIOPATHIC HYPERSOMNIA; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NARCOLEPSY; NARCOLEPSY TYPE 1; NARCOLEPSY TYPE 2; PRIORITY JOURNAL; SMOKING; SUBSTANCE ABUSE; ADOLESCENT; AGED; AROUSAL; CRAVING; DEFICIENCY; DISORDERS OF EXCESSIVE SOMNOLENCE; FRANCE; HYPERSOMNOLENCE, IDIOPATHIC; METABOLISM; MIDDLE AGED; MOTIVATION; SUBSTANCE-RELATED DISORDERS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; AROUSAL; CASE-CONTROL STUDIES; CRAVING; CROSS-SECTIONAL STUDIES; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; FRANCE; HUMANS; HYPERSOMNOLENCE, IDIOPATHIC; MALE; MIDDLE AGED; MOTIVATION; NARCOLEPSY; OREXINS; SMOKING; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84960413296     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.5530     Document Type: Article

References (44)

1. American Academy of Sleep Medicine. International classification of sleep disorders, 3rd ed. Darien, IL: American Academy of Sleep Medicine, 2014.
2. Dauvilliers Y, Paquereau J, Bastuji H, et al. Psychological health in central hypersomnias: the French Harmony study. J Neurol Neurosurg Psychiatry 2009;80:636-41.
3. Fortuyn HA, Mulders PC, Renier WO, et al. Narcolepsy and psychiatry: an evolving association of increasing interest. Sleep Med 2011;12:714-9.
4. Ohayon MM. Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population. Sleep Med 2013;14:488-92.
5. Bayard S, Croisier Langenier M, Cochen De Cock V, et al. Executive control of attention in narcolepsy. PLoS One 2012;7:e33525.
6. Bayard S, Abril B, Yu H, et al. Decision making in narcolepsy with cataplexy. Sleep 2011;34:99-104.
7. Delazer M, Hogl B, Zamarian L, et al. Executive functions, information sampling, and decision making in narcolepsy with cataplexy. Neuropsychology 2011;25:477-87.
8. Dimitrova A, Fronczek R, Van Der Ploeg J, et al. Reward-seeking behavior in human narcolepsy. J Clin Sleep Med 2011;7:293-300.
9. Peyron C, Tighe DK, Van Den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996-10015.
10. Bourgin P, Huitron-Resendiz S, Spier AD, et al. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 2000;20:7760-5.
11. Hagan JJ, Leslie RA, Patel S, et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci U S A 1999;96:10911-6.
12. Burlet S, Tyler CJ, Leonard CS. Direct and indirect excitation of laterodorsal tegmental neurons by hypocretin/orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 2002;22:2862-72.
13. Brown RE, Sergeeva O, Eriksson KS, et al. Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology 2001;40:457-9.
14. Korotkova TM, Sergeeva OA, Eriksson KS, et al. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 2003;23:7-11.
15. Borgland SL, Chang SJ, Bowers MS, et al. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 2009;29:11215-25.
16. Borgland SL, Taha SA, Sarti F, et al. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006;49:589-601.
17. Boutrel B, Kenny PJ, Specio SE, et al. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A 2005;102:19168-73.
18. Harris GC, Wimmer M, Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 2005;437:556-9.
19. Hollander JA, Lu Q, Cameron MD, et al. Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci U S A 2008;105:19480-5.
20. Georgescu D, Zachariou V, Barrot M, et al. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 2003;23:3106-11
21. Plaza-Zabala A, Flores A, Martin-Garcia E, et al. A role for hypocretin/orexin receptor-1 in cue-induced reinstatement of nicotineseeking behavior. Neuropsychopharmacology 2013;38:1724-36.
22. Flores A, Maldonado R, Berrendero F. The hypocretin/orexin receptor-1 as a novel target to modulate cannabinoid reward. Biol Psychiatry 2014;75:499-507.
23. Hollander JA, Pham D, Fowler CD, et al. Hypocretin-1 receptors regulate the reinforcing and reward-enhancing effects of cocaine: pharmacological and behavioral genetics evidence. Front Behav Neurosci 2012;6:47.
24. Lawrence AJ, Cowen MS, Yang HJ, et al. The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 2006;148:752-9.
25. Narita M, Nagumo Y, Hashimoto S, et al. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 2006;26:398-405.
26. Smith RJ, Aston-Jones G. Orexin/hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking. Eur J Neurosci 2012;35:798-804.
27. Bayerlein K, Kraus T, Leinonen I, et al. Orexin A expression and promoter methylation in patients with alcohol dependence comparing acute and protracted withdrawal. Alcohol 2011;45:541-7.
28. Von Der Goltz C, Koopmann A, Dinter C, et al. Orexin and leptin are associated with nicotine craving: a link between smoking, appetite and reward. Psychoneuroendocrinology 2010;35:570-7.
29. Rotter A, Bayerlein K, Hansbauer M, et al. Orexin A expression and promoter methylation in patients with cannabis dependence in comparison to nicotine-dependent cigarette smokers and nonsmokers. Neuropsychobiology 2012;66:126-33.
30. Boutrel B, Steiner N, Halfon O. The hypocretins and the reward function: what have we learned so far? Front Behav Neurosci 2013;7:59.
31. Bayard S, Dauvilliers YA. Reward-based behaviors and emotional processing in human with narcolepsy-cataplexy. Front Behav Neurosci 2013;7:50.
32. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M. I. N. I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59:22-33.
33. Dauvilliers Y, Montplaisir J, Molinari N, et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 2001;57:2029-33.
34. Sommet A, Ferrieres N, Jaoul V, et al. Use of drugs, tobacco, alcohol and illicit substances in a French student population. Therapie 2012;67:429-35.
35. Kenny PJ. Tobacco dependence, the insular cortex and the hypocretin connection. Pharmacol Biochem Behav 2011;97:700-7.
36. Newhouse PA, Potter A, Singh A. Effects of nicotinic stimulation on cognitive performance. Curr Opin Pharmacol 2004;4:36-46.
37. Rusted JM, Sawyer R, Jones C, et al. Positive effects of nicotine on cognition: the deployment of attention for prospective memory. Psychopharmacology (Berl) 2009;202:93-102.
38. Pasumarthi RK, Fadel J. Activation of orexin/hypocretin projections to basal forebrain and paraventricular thalamus by acute nicotine. Brain Res Bull 2008;77:367-73.
39. Ponz A, Khatami R, Poryazova R, et al. Abnormal activity in reward brain circuits in human narcolepsy with cataplexy. Ann Neurol 2010;67:190-200.
40. Degenhardt L, Chiu WT, Sampson N, et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med 2008;5:e141.
41. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499-511.
42. Pattij T, Vanderschuren LJ. The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 2008;29:192-9.
43. Bayard S, Langenier MC, Dauvilliers Y. Effect of psychostimulants on impulsivity and risk taking in narcolepsy with cataplexy. Sleep 2013;36:1335-40.
44. Baumann CR, Mignot E, Lammers GJ, et al. Challenges in diagnosing narcolepsy without cataplexy: a consensus statement. Sleep 2014;37:1035-42